| Financial Year |
March 31 2022 |
| Monetary Funds |
846,222,641.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
16,836,353.56 |
| Accounts Receivable |
341,406,344.71 |
| Advances to Suppliers |
85,631,159.62 |
| Other Receivables |
442,540,170.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
460,699,381.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,048,437.91 |
| Total Current Assets |
2,305,594,630.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
25,861,076.91 |
| Investment Properties |
24,337,337.83 |
| Fixed Assetes |
1,368,794,791.09 |
| Under-construction Projects |
9,912,879.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
184,983,971.10 |
| R&D expenses |
-- |
| Goodwill |
112,200,000.00 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
16,025,364.32 |
| Other Non-Current Assets |
6,074,400.00 |
| Sub-Total of Non-Current Assets |
1,818,451,657.63 |
| Total Assets |
4,124,046,288.06 |
| Short-Term Loans |
165,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
63,600,000.00 |
| Accounts Payable |
284,665,223.46 |
| Accounts Received In Advance |
15,729,814.13 |
| Employee Compensation Payable |
234,780,395.37 |
| Taxes Payable |
21,452,183.22 |
| Interest Payable |
7,471,357.75 |
| Dividend Payable |
606,023.92 |
| Other payables |
519,267,035.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,209,475.34 |
| Other Current Liabilities |
17,996,956.91 |
| Sub-Total of Current Liabilities |
1,572,795,410.48 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
922,161,319.52 |
| Special Payable |
-- |
| Estimatied Liabilities |
62,419,968.51 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,119,082,394.20 |
| Total Liabilities |
2,691,877,804.68 |
| Paid-In Capital(Or Share Stock) |
2,132,890,071.00 |
| Capital Surplus |
2,304,554,210.82 |
| Surplus Reserve |
40,077,376.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,398,967,566.54 |
| Minority Stockholder's Interest |
353,614,391.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,078,554,091.61 |
| Owner's Equity（Stockholder's Equity） |
1,432,168,483.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,124,046,288.06 |
